搜尋結果
文章
Cheng, C. Y. ,
Chu, C. H. ,
Hsu, H. W. ,
Hsu, F. R. ,
Tang, C. Y. ,
Wang, W. C. ,
Kung, H. J. &
Chang, P. C. ,
1月 24 2014 ,
於: BMC Genomics. 15 ,
p. 1-14 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Sumoylation
100%
Chromatin Immunoprecipitation
82%
Transcription Factors
55%
Binding Sites
30%
Post Translational Protein Processing
11%
Shieh, J. M. ,
Shen, C. J. ,
Chang, W. C. ,
Cheng, H. C. ,
Chan, Y. Y. ,
Huang, W. C. ,
Chang, W. C. &
Chen, B. K. ,
6月 12 2014 ,
於: PLoS One. 9 ,
6 , e99242.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Aryl Hydrocarbon Receptor Nuclear Translocator
100%
Cell Death
66%
Reactive Oxygen Metabolite
58%
cell death
58%
hydrocarbons
57%
Chen, S. H. ,
Fan, C. K. ,
Miser, J. S. ,
Liu, Y-L. ,
Huang, Y. J. &
Wang, C. Y. ,
4月 1 2015 ,
於: Journal of Microbiology, Immunology and Infection. 48 ,
2 ,
p. 233-235 3 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chao, C. C. ,
Jen, W. Y. ,
Hung, M. C. ,
Li, Y. C. &
Chi, Y. P. ,
6月 2007 ,
於: Technovation. 27 ,
6-7 ,
p. 342-351 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Patient Safety
100%
Health Care Providers
71%
Health care
60%
Taiwan
45%
Service System
26%
Leung, S. W. ,
Chou, C. J. ,
Huang, T. C. &
Yang, P. M. ,
10月 2019 ,
於: Cancers. 11 ,
10 , 1482.
研究成果: 雜誌貢獻 › 文章 › 同行評審
AT-Hook Motifs
100%
Niclosamide
99%
Drug Repositioning
82%
Computational Biology
56%
Colorectal Neoplasms
47%
Chuang, Y. H. ,
Lee, C. H. ,
Lin, C. Y. ,
Liu, C. L. ,
Huang, S. H. ,
Lee, J. Y. ,
Chiu, Y. Y. ,
Lee, J. C. &
Yang, J. M. ,
5月 2020 ,
於: Cancers. 12 ,
5 , 1324.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Squamous Cell Carcinoma of Head and Neck
100%
Head and Neck Neoplasms
90%
Biomarkers
58%
Smokers
57%
Smoking
48%
Su, F. H. ,
Huang, Y. L. ,
Sung, F. C. ,
Su, C. T. ,
Hsu, W. H. ,
Chang, S. N. &
Yeh, C. C. ,
1月 2 2016 ,
於: Vaccine. 34 ,
1 ,
p. 120-127 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
chronic hepatitis B
100%
HBV
96%
influenza vaccination
91%
Hepatitis B virus
74%
vaccination
59%
El Dika, I. ,
Lim, H. Y. ,
Yong, W. P. ,
Lin, C. C. ,
Yoon, J. H. ,
Modiano, M. ,
Freilich, B. ,
Choi, H. J. ,
Chao, T. Y. ,
Kelley, R. K. ,
Brown, J. ,
Knox, J. ,
Ryoo, B. Y. ,
Yau, T. &
Abou-Alfa, G. K. ,
6月 2019 ,
於: Oncologist. 24 ,
6 ,
p. 747-e218 研究成果: 雜誌貢獻 › 文章 › 同行評審
polo-like kinase 1
100%
Maximum Tolerated Dose
58%
Hepatocellular Carcinoma
53%
Pharmacokinetics
49%
Safety
38%
Chao, M. W. ,
Huang, H. L. ,
HuangFu, W. C. ,
Hsu, K. C. ,
Liu, Y. M. ,
Wu, Y. W. ,
Lin, C. F. ,
Chen, Y. L. ,
Lai, M. J. ,
Lee, H. Y. ,
Liou, J. P. ,
Teng, C. M. &
Yang, C. R. ,
2017 ,
於: Oncotarget. 8 ,
17 ,
p. 27772-27785 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
quinoline
100%
Leukemia
42%
Glycoproteins
29%
Pharmaceutical Preparations
28%
Neoplasms
22%
Kuo, L. J. ,
Ngu, J. C. Y. ,
Huang, Y. J. ,
Lin, Y. K. ,
Chen, C. C. ,
Tong, Y. S. ,
Huang, S. C. ,
Hu, C. C. &
Tan, S. H. ,
11月 1 2017 ,
於: Surgical Endoscopy and Other Interventional Techniques. 31 ,
11 ,
p. 4466-4471 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Robotics
100%
Rectal Neoplasms
97%
Hemorrhoids
50%
Ambulatory Surgical Procedures
36%
Prolapse
21%
Chen, M. ,
Sheu, M. T. ,
Cheng, T. L. ,
Roffler, S. R. ,
Lin, S. Y. ,
Chen, Y. J. ,
Cheng, Y. A. ,
Cheng, J. J. ,
Chang, H. Y. ,
Wu, T. Y. ,
Kao, A. P. ,
Ho, Y. S. &
Chuang, K. H. ,
1月 7 2022 ,
於: Biomaterials Science. 10 ,
1 ,
p. 202-215 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Medical nanotechnology
100%
Fibroblasts
84%
Glycols
73%
Antibodies
73%
Doxorubicin
60%
Su, C. M. ,
Chang, T. Y. ,
Hsu, H. P. ,
Lai, H. H. ,
Li, J. N. ,
Lyu, Y. J. ,
Kuo, K. T. ,
Huang, M. T. ,
Su, J. L. &
Chen, P. S. ,
2016 ,
於: Oncotarget. 7 ,
39 ,
p. 63924-63936 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
ErbB Receptors
100%
Breast Neoplasms
66%
Lapatinib
29%
Erlotinib Hydrochloride
26%
Gefitinib
26%
Wang, L. T. ,
Liou, J. P. ,
Li, Y. H. ,
Liu, Y. M. ,
Pan, S. L. &
Teng, C. M. ,
2014 ,
於: Oncotarget. 5 ,
14 ,
p. 5651-5662 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylases
100%
Cadherins
86%
Protein Kinase C
81%
Cell Differentiation
69%
Colorectal Neoplasms
68%
Wu, Y. W. ,
Hsu, K. C. ,
Lee, H. Y. ,
Huang, T. C. ,
Lin, T. E. ,
Chen, Y. L. ,
Sung, T. Y. ,
Liou, J. P. ,
Hwang-Verslues, W. W. ,
Pan, S. L. &
HuangFu, W. C. ,
3月 13 2018 ,
於: Frontiers in Pharmacology. 9 ,
MAR , 205.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Tubulin Modulators
100%
In Vitro Techniques
26%
Tubulin
26%
Histone Deacetylase 6
19%
Neoplasms
19%
Wu, Y. W. ,
Chao, M. W. ,
Tu, H. J. ,
Chen, L. C. ,
Hsu, K. C. ,
Liou, J. P. ,
Yang, C. R. ,
Yen, S. C. ,
HuangFu, W. C. &
Pan, S. L. ,
5月 2021 ,
於: Oncogenesis. 10 ,
5 , 39.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase Inhibitors
100%
Leukemia
69%
Down-Regulation
59%
In Vitro Techniques
37%
Mitogen-Activated Protein Kinase Kinases
23%
Microbial fuel cells
100%
fuel cells
89%
Membranes
64%
membranes
56%
Anodes
37%
Apoptosis Induction
100%
Histone
73%
Antitumor
62%
Safety
58%
Colorectal Neoplasms
54%
Chang, T. Y. ,
Nepali, K. ,
Chen, Y. Y. ,
Yang, Y. C. S. H. ,
Hsu, K. C. ,
Yen, Y. ,
Pan, S. L. ,
Liou, J. P. &
Lee, S. B. ,
6月 2021 ,
於: Biomedicine and Pharmacotherapy. 138 , 111485.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase Inhibitors
100%
Histone Deacetylases
99%
Cell Cycle Checkpoints
83%
Mitosis
28%
Epigenomics
24%
Leung, S. W. ,
Cheng, P. C. ,
Chou, C. M. ,
Lin, C. ,
Kuo, Y. C. ,
Lee, Y. L. A. ,
Liu, C. Y. ,
Mi, F. L. &
Cheng, C. H. ,
1月 1 2022 ,
於: International Journal of Biological Macromolecules. 194 ,
p. 384-394 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chitosan
100%
Polyglutamic Acid
82%
Nucleic acids
75%
Molecular weight
57%
Larva
54%
Chang, Y. T. ,
Syed-Abdul, S. ,
Tsai, C. Y. &
Li, Y. C. ,
12月 2011 ,
於: International Journal of Medical Informatics. 80 ,
12 ,
p. 872-880 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Radio Frequency Identification Device
100%
History
44%
Caregivers
30%
Cross Infection
23%
Intensive Care Units
19%
Chien, S. C. ,
Chin, Y. P. H. ,
Yoon, C. H. ,
Islam, M. M. ,
Jian, W. S. ,
Hsu, C. K. ,
Chen, C. Y. ,
Chien, P. H. &
Li, Y. C. J. ,
2月 2021 ,
於: PLoS ONE. 16 ,
2 February , e0246597.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Medical Order Entry Systems
100%
physicians
73%
Hospital Administrators
38%
collectors
37%
Programming Languages
19%
Ho, C. T. ,
Chang, Y. J. ,
Yang, L. X. ,
Wei, P. L. ,
Liu, T. Z. &
Liu, J. J. ,
9月 10 2015 ,
於: PLoS One. 10 ,
9 , e0136340.
研究成果: 雜誌貢獻 › 文章 › 同行評審
hepatoma
100%
Cell Death
97%
Microtubules
88%
microtubules
86%
cell death
84%
Wen, Y. T. ,
Wu, A. T. ,
Bamodu, O. A. ,
Wei, L. ,
Lin, C. M. ,
Yen, Y. ,
Chao, T. Y. ,
Mukhopadhyay, D. ,
Hsiao, M. &
Huang, H. S. ,
10月 1 2019 ,
於: Cancers. 11 ,
10 , 1442.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Glioblastoma
100%
Temozolomide
94%
Phenotype
60%
Glioma
58%
Stem Cells
46%
Liou, J. P. ,
Hsu, K. S. ,
Kuo, C. C. ,
Chang, C. Y. &
Chang, J. Y. ,
10月 2007 ,
於: Journal of Pharmacology and Experimental Therapeutics. 323 ,
1 ,
p. 398-405 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
N-(1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl)isonicotinamide
100%
indoline
70%
Sulfonamides
48%
Human Activities
38%
Microtubules
37%
Hsieh, C-L. ,
Huang, H-S. ,
Chen, K-C. ,
Saka, T. ,
Chiang, C-Y. ,
Chung, L. W. K. &
Sung, S-Y. ,
1月 1 2020 ,
於: Molecular Cancer Therapeutics. 19 ,
1 ,
p. 101-111 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
salicylanilide
100%
Castration
57%
Autophagy
49%
Prostatic Neoplasms
40%
Cell Death
39%
Yu, C. C. ,
Pan, S. L. ,
Chao, S. W. ,
Liu, S. P. ,
Hsu, J. L. ,
Yang, Y. C. ,
Li, T. K. ,
Huang, W. J. &
Guh, J. H. ,
8月 1 2014 ,
於: Biochemical Pharmacology. 90 ,
3 ,
p. 320-330 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
N-hydroxy-6-(4-carbamoylacridinyl)hexanamide
100%
Vorinostat
67%
Histone Deacetylases
45%
Histone
41%
Human Activities
38%
Chiang, N. J. ,
Lin, C. I. ,
Liou, J. P. ,
Kuo, C. C. ,
Chang, C. Y. ,
Chen, L. T. &
Chang, J. Y. ,
3月 12 2013 ,
於: PLoS ONE. 8 ,
3 , e58953.
研究成果: 雜誌貢獻 › 文章 › 同行評審
5-amino-6-methoxy-2-(3',4',5'-trimethoxybenzoyl)quinoline
100%
Cell Death
41%
tubulin
39%
Human Activities
38%
Microtubules
37%
Huang, C. W. ,
Syed-Abdul, S. ,
Jian, W. S. ,
Iqbal, U. ,
Nguyen, P. A. A. L. ,
Lee, P. ,
Lin, S. H. ,
Hsu, W. D. ,
Wu, M. S. ,
Wang, C. F. ,
Ma, K. L. &
Li, Y. C. J. A. ,
3月 1 2015 ,
於: Journal of the American Medical Informatics Association. 22 ,
2 ,
p. 290-298 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Taiwan
100%
Chronic Renal Insufficiency
92%
Cohort Studies
68%
Comorbidity
33%
National Health Programs
15%
Chen, C. W. ,
Lee, Y. L. ,
Liou, J. P. ,
Liu, Y. H. ,
Liu, C. W. ,
Chen, T. Y. &
Huang, H. M. ,
9月 1 2016 ,
於: Apoptosis. 21 ,
9 ,
p. 1008-1018 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
N-(1-4-methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-7-yl)formamide
100%
Tubulin Modulators
63%
Imatinib Mesylate
44%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
40%
Myeloid Cells
39%
Hsiao, K. C. ,
Shih, N. Y. ,
Chu, P. Y. ,
Hung, Y. M. ,
Liao, J. Y. ,
Chou, S. W. ,
Yang, Y. Y. ,
Chang, G. C. &
Liu, K. J. ,
2015 ,
於: Oncotarget. 6 ,
33 ,
p. 35073-35086 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Phosphopyruvate Hydratase
100%
Lung Neoplasms
67%
Non-Small Cell Lung Carcinoma
45%
Circulating Neoplastic Cells
21%
Regulatory T-Lymphocytes
16%
Chen, C. P. ,
Hu, C. B. ,
Yeh, K. C. ,
Song, J. S. ,
Yeh, T. K. ,
Tung, F. F. ,
Hwang, L. L. ,
Tseng, H. Y. ,
Huang, Y. C. ,
Shy, H. S. ,
Hsieh, S. H. ,
Shen, C. C. ,
Wang, H. S. ,
Hsieh, H. P. ,
Liou, J. P. ,
Chao, Y. S. &
Chen, C. T. ,
7月 2010 ,
於: Anticancer Research. 30 ,
7 ,
p. 2813-2822 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cisplatin
39%
Nude Mice
20%
matrigel
16%
Human Umbilical Vein Endothelial Cells
15%
fosbretabulin
12%
Wang, J. H. ,
Shih, K. S. ,
Liou, J. P. ,
Wu, Y. W. ,
Chang, A. S. Y. ,
Wang, K. L. ,
Tsai, C. L. &
Yang, C. R. ,
2月 16 2012 ,
於: PLoS One. 7 ,
2 , e31368.
研究成果: 雜誌貢獻 › 文章 › 同行評審
magnolol
100%
Antiarthritic
94%
Magnolol
93%
Synoviocytes
78%
arthritis
70%
Huang, C. C. ,
Rwei, S. P. ,
Jang, C. S. ,
Tsen, W. C. ,
Chuang, F. S. ,
Ku, T. H. ,
Chow, J. D. ,
Chen, C-C. &
Shu, Y. C. ,
3月 1 2017 ,
於: Journal of Nanoscience and Nanotechnology. 17 ,
3 ,
p. 1975-1982 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
urethanes
100%
Electrospinning
98%
Polydimethylsiloxane
91%
Silver
79%
Urethane
78%
Lee, C. H. ,
Lee, Y. C. ,
Liang, M. H. ,
Leu, S. J. ,
Lin, L. T. ,
Chiang, J. R. &
Yang, Y. Y. ,
2016 ,
於: Applied and Environmental Microbiology. 82 ,
1 ,
p. 71-80 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
venom
100%
Snake Venoms
96%
snake venoms
87%
snake
85%
antibody
76%
Mokgautsi, N. ,
Kuo, Y. C. ,
Tang, S. L. ,
Liu, F. C. ,
Chen, S. J. ,
Wu, A. T. H. &
Huang, H. S. ,
1月 1 2022 ,
於: Cancers. 14 ,
1 , 262.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Mitogen-Activated Protein Kinase 7
100%
Glioblastoma
87%
Cell Cycle
70%
Cyclin B1
65%
Temozolomide
24%
Huang, Y. C. ,
Huang, F. I. ,
Mehndiratta, S. ,
Lai, S. C. ,
Liou, J. P. &
Yang, C. R. ,
2015 ,
於: Oncotarget. 6 ,
21 ,
p. 18590-18601 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
MPT0G157
100%
Histone Deacetylases
32%
Growth
19%
Neoplasms
12%
Vorinostat
7%
Mwale, P. F. ,
Lee, C-H. ,
Leu, S-J. ,
Lee, Y-C. ,
Wu, H-H. ,
Lin, L-T. ,
Lin, T. E. ,
Huang, Y-J. &
Yang, Y-Y. ,
7月 4 2019 ,
於: Applied Microbiology and Biotechnology. 103 ,
13 ,
p. 5285-5299 15 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
OMPA outer membrane proteins
100%
Single-Chain Antibodies
80%
Epitopes
53%
Escherichia coli
43%
Amino Acids
43%
Wang, T. Y. ,
Su, N. Y. ,
Shih, P. C. ,
Tsai, P. S. &
Huang, C. J. ,
12月 1 2014 ,
於: Journal of Surgical Research. 192 ,
2 ,
p. 599-606 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Naloxone
100%
Phosphatidylinositol 3-Kinase
95%
Inflammation
55%
5-(5-(4-fluoro-2-hydroxyphenyl)furan-2-ylmethylene)thiazolidine-2,4-dione
50%
IC 87114
46%
Chen, R-M. ,
Chen, T-G. ,
Chen, T-L. ,
Lin, L. L. ,
Chang, C. C. ,
Chang, H-C. &
Wu, C-H. ,
2005 ,
於: Annals of the New York Academy of Sciences. 1042 ,
p. 262-271 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Propofol
100%
Antiinflammatory
62%
Lipopolysaccharides
56%
Antioxidant Agent
50%
Anti-Inflammatory Agents
48%
Huangfu, W. C. ,
Chao, M. W. ,
Cheng, C. C. ,
Wei, Y. C. ,
Wu, Y. W. ,
Liou, J. P. ,
Hsiao, G. ,
Lee, Y. C. &
Yang, C. R. ,
2月 9 2017 ,
於: Scientific Reports. 7 , 42291.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Antileukemic Agent
100%
Vincristine
91%
Cleavage
84%
Poly(ADPribose)
84%
Cytotoxic Agent
77%
Hsieh, Y. L. ,
Tu, H. J. ,
Pan, S. L. ,
Liou, J. P. &
Yang, C. R. ,
6月 1 2019 ,
於: Biochimica et Biophysica Acta - Molecular Cell Research. 1866 ,
6 ,
p. 992-1003 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase 6
100%
Triple Negative Breast Neoplasms
74%
Histone Deacetylase Inhibitors
72%
Breast Neoplasms
39%
Acetylation
27%
Chang, C. Y. ,
Chuang, H. Y. ,
Lee, H. Y. ,
Yeh, T. K. ,
Kuo, C. C. ,
Chang, C. Y. ,
Chang, J. Y. &
Liou, J. P. ,
4月 22 2014 ,
於: European Journal of Medicinal Chemistry. 77 ,
p. 306-314 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Benzophenones
100%
Vascular Targeting Agent
95%
fosbretabulin
89%
Antimitotic
79%
Antimitotic Agents
77%
Dioscorea
100%
Dipeptides
83%
homocarnosine
79%
yams
78%
dipeptides
77%
Huang, S. H. ,
Chen, C. C. ,
Lin, C. M. &
Chiang, B. H. ,
8月 2008 ,
於: Journal of Food Composition and Analysis. 21 ,
5 ,
p. 402-409 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Angelica sinensis
100%
flavor
51%
phenolic acid
49%
Antioxidants
45%
antioxidants
40%
Wu, T. H. ,
Wang, P. W. ,
Lin, T. Y. ,
Yang, P. M. ,
Li, W. T. ,
Yeh, C. T. &
Pan, T. L. ,
12月 2021 ,
於: Biomedicine and Pharmacotherapy. 144 , 112284.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Rubus
100%
Fibrosis
48%
Antioxidants
48%
Apoptosis
40%
Liver
34%
Hong, C. T. ,
Chan, L. ,
Wu, D. ,
Chen, W. T. &
Chien, L. N. ,
1月 1 2019 ,
於: Parkinsonism and Related Disorders. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cholinergic Antagonists
100%
Parkinson Disease
75%
Dementia
75%
Propensity Score
8%
Tremor
8%
Jeng, J. H. ,
Wu, H. L. ,
Lin, B. R. ,
Lan, W. H. ,
Chang, H. H. ,
Ho, Y. S. ,
Lee, P. H. ,
Wang, Y. J. ,
Wang, J. S. ,
Chen, Y. J. &
Chang, M. C. ,
4月 2007 ,
於: Atherosclerosis. 191 ,
2 ,
p. 250-258 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
sanguinarine
100%
Thromboxanes
73%
Calcium
40%
Arachidonic Acid
24%
Platelet Aggregation
24%
Chin, Y. T. ,
Hsieh, M. T. ,
Yang, S. H. ,
Tsai, P. W. ,
Wang, S. H. ,
Wang, C. C. ,
Lee, Y. S. ,
Cheng, G. Y. ,
HuangFu, W. C. ,
London, D. ,
Tang, H. Y. ,
Fu, E. ,
Yen, Y. ,
Liu, L. F. ,
Lin, H. Y. &
Davis, P. J. ,
2014 ,
於: Oncotarget. 5 ,
24 ,
p. 12891-12907 17 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Resveratrol
100%
Breast Neoplasms
54%
Gene Expression
51%
In Vitro Techniques
37%
Stilbenes
30%
Tsai, J. C. ,
Lin, Y. K. ,
Huang, Y. J. ,
Loh, E. W. ,
Wen, H. Y. ,
Wang, C. H. ,
Tsai, Y. T. ,
Hsieh, W. S. &
Tam, K. W. ,
4月 1 2017 ,
於: Infection Control and Hospital Epidemiology. 38 ,
4 ,
p. 417-422 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Povidone-Iodine
100%
Local Anti-Infective Agents
91%
Chlorhexidine
90%
Hand
56%
Randomized Controlled Trials
50%
Povidone-Iodine
100%
Local Anti-Infective Agents
91%
Chlorhexidine
90%
chlorhexidine gluconate
68%
Hand
56%